The data show that Regorafenib is equivalent to TAS-102 in metastatic CRC.

Published Date: 08 Mar 2023

A real-world comparison showed similar overall survival in patients with refractory metastatic CRC treated with regorafenib or trifluridine/tipiracil (TAS-102).

Read Full News

Latest News

How the gut builds long-lasting immunity after viral infections

A new study led by University of Toronto researchers has shown that immune cells in the gut follow an atypical pathway to produce antibodies that provide long-term protection against viruses.

Medications change our gut microbiome in predictable ways, research reveals

Our gut microbiome is made up of trillions of bacteria and other microbes living in our intestines. These help our bodies break down food, assist our immune system, send chemical signals to our brain, and potentially serve ...

Researchers find simple way to make kale healthier by pairing it with oil-based dressings

Think that kale salad you're eating is a superfood? Without the right ingredient it might not be living up to its hype. But don't worry.

New drug offers hope to bladder cancer patients

Imagine a targeted approach to bladder cancer that spares healthy cells while delivering chemotherapy directly to cancerous ones, offering hope for patients with advanced stages of the disease.

Don't let food poisoning crash your Thanksgiving dinner

Thanksgiving is a time for family, friends and feasting. However, amid the joy of gathering and indulging in delicious food, it is essential to keep food safety in mind. Foodborne illnesses can quickly put a damper on your ...

How weakness in cell structure affects the host–microbiome relationship

Cells have an internal skeleton that maintains their structure and also drives their movement. Known as the cytoskeleton, this scaffold is composed of a network of dynamic filaments made of a protein called actin.

Todays Updates

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Addressing Fibromyalgia Sleep and Pain With TNX-102 SL Approval: Q&A With Philip Mease, MD Philip J. Mease, MD

Mease discussed his hopes for the new approval's impact on the fibromyalgia field.

7 Rheumatology Headlines You Missed in September 2025 Victoria Johnson

The rheumatology month in review emphasizes new approvals and the latest comparative research.

Q3 2025 Recap: 7 Top FDA Approvals to Know Victoria Johnson

Q3 2025 saw several new first targeted therapies for rare and more individualized indications in a number of fields.

Q3 2025 Recap: Rheumatology News and Updates Victoria Johnson

Q3 2025 saw a number of exciting approvals and data on promising therapies in development.

Bridging the Treatment Gap in Pediatric Psoriasis and PsA With Guselkumab, With Vimal H. Prajapati, MD Vimal H. Prajapati, MD

Prajapati discussed the impact of the expanded approval of guselkumab to pediatric PsO and psoriatic arthritis.

Sonelokimab Demonstrates Psoriatic Arthritis Improvements Over Placebo Victoria Johnson

Sonelokimab meets ACR50 primary endpoint in a phase 2 trial.

Todays Updates

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Addressing Fibromyalgia Sleep and Pain With TNX-102 SL Approval: Q&A With Philip Mease, MD Philip J. Mease, MD

Mease discussed his hopes for the new approval's impact on the fibromyalgia field.

7 Rheumatology Headlines You Missed in September 2025 Victoria Johnson

The rheumatology month in review emphasizes new approvals and the latest comparative research.

Q3 2025 Recap: 7 Top FDA Approvals to Know Victoria Johnson

Q3 2025 saw several new first targeted therapies for rare and more individualized indications in a number of fields.

Q3 2025 Recap: Rheumatology News and Updates Victoria Johnson

Q3 2025 saw a number of exciting approvals and data on promising therapies in development.

Bridging the Treatment Gap in Pediatric Psoriasis and PsA With Guselkumab, With Vimal H. Prajapati, MD Vimal H. Prajapati, MD

Prajapati discussed the impact of the expanded approval of guselkumab to pediatric PsO and psoriatic arthritis.

Sonelokimab Demonstrates Psoriatic Arthritis Improvements Over Placebo Victoria Johnson

Sonelokimab meets ACR50 primary endpoint in a phase 2 trial.

Latest News

A new study led by University of Toronto researchers has shown that immune cells in the gut follow an atypical pathway to produce antibodies that provide long-term protection against viruses.

Our gut microbiome is made up of trillions of bacteria and other microbes living in our intestines. These help our bodies break down food, assist our immune system, send chemical signals to our brain, and potentially serve ...

Think that kale salad you're eating is a superfood? Without the right ingredient it might not be living up to its hype. But don't worry.

Imagine a targeted approach to bladder cancer that spares healthy cells while delivering chemotherapy directly to cancerous ones, offering hope for patients with advanced stages of the disease.

Thanksgiving is a time for family, friends and feasting. However, amid the joy of gathering and indulging in delicious food, it is essential to keep food safety in mind. Foodborne illnesses can quickly put a damper on your ...

Cells have an internal skeleton that maintains their structure and also drives their movement. Known as the cytoskeleton, this scaffold is composed of a network of dynamic filaments made of a protein called actin.

News All Time

Combination therapy for pancreatic cancer offers new treatment approach

Pancreatic cancer, also known as pancreatic ductal adenocarcinoma, is one of the most aggressive types of cancer. Despite advances in modern medicine, survival rates remain very low, and many patients develop resistance to ...

The case for a cancer warning on processed meat

A group of scientists in the UK recently demanded that bacon and ham products carry health warnings similar to those on cigarettes.

New insights on gut microbes that prevent formation of cancer-causing compounds

Nitrogen metabolism of gut bacteria can provide health benefits. Specifically, gut microbes metabolize dietary nitrates and nitrites and prevent the formation of cancer-causing compounds called nitrosamines. New research ...

As millions lag in colon cancer screening, new studies point to strategies to boost uptake and follow-up

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a non-invasive test.

Exploring interactions between gut microbiota and sleep disorders through the brain-gut axis

A comprehensive review published in Brain Medicine illuminates the intricate connections between gut microbiota and sleep regulation, establishing the microbiota-gut-brain axis as a critical pathway in understanding and potentially ...

Study shows semaglutide, tirzepatide and dulaglutide have similar gastrointestinal safety profiles in clinical settings

A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients with type 2 diabetes (T2D). The study found that the medications have similar ...

Gut microbiome tests are everywhere. Should you get one?

At-home gut microbiome tests are trending, selling insights to the curious, empowerment to the chronically ill and a claimed path to longevity to the wellness-conscious.

Device provides 'smart toilet' feedback on health

A new "smart toilet" device aims to help people track their health by analyzing their bathroom trips.

Study finds surprising link between gut and brain rhythms

The human body is packed with natural rhythms, from your sleep-wake cycle to the steady pulsing of blood through the brain to heart rate and pulse.

Dietary fiber, prunes and senna offer relief for constipation discomfort

Big-gun pain relievers can come with unwelcome side effects. At the top of the list for many of these products are constipation and the distress of slowed bowels.

Q&A: Bacteria research could be a gut-punch to inflammatory bowel disease

The group of lifelong intestinal conditions known as inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, significantly impacts digestive health and quality of life for an estimated 2.4 ...

Researchers map how gut neurons respond to bacteria, parasites and food allergies

The enteric nervous system (ENS) is a vast network of nerves built into the walls of the intestine. While it is well known for its role in regulating digestion and the movement of food through the intestine, researchers are ...

Maxing out your fiber intake can have broad health benefits

The amount of fiber you consume can have significant impacts on your body. From healthy digestion, to reducing your risk of developing cancer, eating fiber has huge benefits—which may be why the fibermaxxing trend is taking ...

Babies' gut bacteria may influence future emotional health

A child's early gut microbiome may influence their risk of developing depression, anxiety or other internalizing symptoms in middle childhood, according to a new UCLA Health study. The effect appears to be related to the ...

Demographic disparities found in uptake of colorectal cancer screenings

Colorectal cancer (CRC) screening is considered one of the most effective and successful tools to protect public health: Screening has been found to significantly reduce the incidence of CRC through the removal of precancerous ...

1 in 10 people without celiac disease or wheat allergy report sensitivity to gluten or wheat, finds study

Around one in ten people worldwide report gastrointestinal and other symptoms such as fatigue and headache after eating foods containing gluten or wheat despite not having a diagnosis of either celiac disease or wheat allergy, ...

Recommended News For You

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

Patient Endured 9 Years of Chemotherapy for Cancer He Never Had

enhancing survivors of brain tumors' quality of life.

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

Recommended Articles For You

Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients 

Different Types of Blood Dyscrasias  

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential 

Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

2.

Brain cancer: a Q&A session.

3.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

4.

Daily physical activity, even at light intensities, linked to lower cancer risk

5.

Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer

1.

A Revolutionary Guide to Calculating Absolute Neutrophil Counts

2.

Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research

3.

Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective

4.

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment

5.

Synovial Sarcoma of Female Urethra: Case Report and Literature Review

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

3.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot